Patent directory · USPTO A61K / A61P
Patents matching “Ludwig-Maximilians-Universitat Munchen”
34 pharma patents match "Ludwig-Maximilians-Universitat Munchen" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 34 pharmaceutical patents matching "Ludwig-Maximilians-Universitat Munchen" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12391732
Articles comprising a silk polypeptide for antigen delivery
granted -
US 12171837
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11827678
Articles comprising a silk polypeptide for antigen delivery
granted -
US 11746124
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11723922
CXCR6-transduced T cells for targeted tumor therapy
granted -
US 11667683
Articles comprising a silk polypeptide for antigen delivery
granted -
US 11229700
Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition
granted -
US 11180518
Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma
granted -
US 11161873
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11104708
Articles comprising a silk polypeptide for antigen delivery
granted -
US 10941200
TREM2 cleavage modulators and uses thereof
granted -
US 10822378
Mutated structural protein of a parvovirus
granted -
US 10633451
Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine
granted -
US 10435373
Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
granted -
US 10408834
Mutated parvovirus structural proteins as vaccines
granted -
US 10071966
Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases
granted -
US 9750717
Inhibitors of CD40-TRAF6 interaction
granted -
US 9718811
(S)-enantiomer of mepazine
granted -
US 9678061
Identification of T cell target antigens
granted -
US 9658230
Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB
granted -
US 9624274
Mutated structural protein of a parvovirus
granted -
US 9521845
Beta-lactones as antibacterial agents
granted -
US 9415087
Compositions and methods for treating coronavirus infection
granted -
US 9408829
Inhibitors of CD40-TRAF6 interaction
granted